GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,000 | -57.1% | 30 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $7,000 | +133.3% | 30 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $3,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | -25.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -42.9% | 30 | -60.0% | 0.00% | -50.0% |
| Q1 2020 | $7,000 | +133.3% | 75 | +150.0% | 0.00% | +100.0% |
| Q4 2019 | $3,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $3,000 | -40.0% | 30 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $5,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $5,000 | +66.7% | 30 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $3,000 | -40.0% | 30 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $5,000 | +25.0% | 30 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $4,000 | +33.3% | 30 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | -25.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $4,000 | +33.3% | 30 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $3,000 | 0.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $3,000 | -25.0% | 30 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $4,000 | -99.9% | 30 | 0.0% | 0.00% | +100.0% |
| Q4 2016 | $3,353,000 | +83725.0% | 30 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $4,000 | +33.3% | 30 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $3,000 | +50.0% | 30 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $2,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|